← Home / Forte Biosciences, Inc. (FBRX)
Stock Analysis
Forte Biosciences, Inc. (FBRX)
FBRX
FBRX · Market data
21.03 +12.40%
52W Range Position
44%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-06-26 21:23 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
Fundamentals
Insufficient / Insufficient
Price Structure
Vulnerable
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
Break Above
Confirmation improves above resistance.
21.44
🎯
Next Objective
Pattern-derived target if setup continues.
8.22
×
Thesis Break
Scenario weakens below invalidation.
Below —
What's Driving FBRX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 21.44 for confirmation and for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 15.97 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Pattern
Triangle Compression / SYM / UP
State
Active
Trigger
18.68
Risk / Invalid
11.99
Compression
27%
RSI(14)
58.0
How to read this setup
The next meaningful technical decision is likely to occur between support at 15.97 and resistance at 21.44. A move through resistance would be needed to materially improve the chart, while a break of support would keep the pressure side dominant. Pattern-based invalidation is near 36.87; losing that area would weaken the active formation considerably.
Price Chart
FBRX · WOI overlay chart
Open Full Workspace
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
Revenue Growth
Insufficient
Profitability
Insufficient
Cash Flow
Mixed
Balance Sheet
Manageable
💵 Revenue
9,000
≈ Insufficient
📈 Net Income
-22.14M
≈ Insufficient
🧮 EPS (Basic)
-1.24
≈ Insufficient
Forte Biosciences, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.